Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intranasal application of vesicular
stomatitis
virus (VSV) results in the initial infection of the olfactory receptor neurons and a rapid progression of the virus through the mouse central nervous system (CNS).
Interleukin-18
(
IL-18
) is an 18.3-kd cytokine that induces interferon gamma (IFN-gamma) production in mice.
IL-18
is synthesized as an inactive precursor that is cleaved and activated by caspase-1/interleukin-1beta converting enzyme (ICE).
IL-18
shares several biological properties with IL-12, including the ability to induce IFN-gamma production in T lymphocytes and natural killer (NK) cells. In the CNS, microglia and astrocytes produce
IL-18
and IL-12. We have previously shown that IL-12 promotes recovery from VSV encephalitis. This led us to examine the potential role of
IL-18
in the pathogenesis of VSV encephalitis. We show that both
IL-18
and caspase-1 mRNA are consistently present in the CNS of mice. The addition of exogenous
IL-18
to cell cultures does not affect the production of VSV, and addition of exogenous
IL-18
at the time of infection does not alter the morbidity or mortality of BALB/c mice. In vitro studies with neutralizing monoclonal antibody to
IL-18
had no effect. From these results we conclude that in this system and under the experimental conditions used, unlike IL-12 and IFN-gamma,
IL-18
does not play a significant role in the host response to VSV infection.
...
PMID:The role of interleukin-18 in vesicular stomatitis virus infection of the CNS. 1139 13